Copyright
©The Author(s) 2015.
World J Respirol. Jul 28, 2015; 5(2): 166-175
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.166
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.166
Table 2 Diagnostic yield of restaging procedures in non-small-cell lung cancer after neoadjuvant therapy (%)
| Diagnostic technique | SensitivityMean (range) | SpecificityMean (range) | Negative predictive valueMean (range) |
| Chest CT | 55 (20-91) | 81 (50-97) | 83 (54-97) |
| PET/CT | 77 (33-100) | 86 (43-100) | 91 (79-100) |
| EBUS/TBNA | 89 (46-97) | 100 (96-100) | 91 (60-99) |
| EUS/FNA | 89 (45-100) | 100 (90-100) | 86 (68-100) |
| Mediastinoscopy | 78 (32-92) | 100 | 91 (80-97) |
| Video-mediastinoscopy | 89 (78-97) | 100 | 92 (83-96) |
| VATS | 99 (58-100) | 100 | 96 (88-100) |
| VAMLA | 93.8 | 100 | 96 |
| TEMLA | 96.2 | 100 | 98.9 |
- Citation: Zielinski M. Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer. World J Respirol 2015; 5(2): 166-175
- URL: https://www.wjgnet.com/2218-6255/full/v5/i2/166.htm
- DOI: https://dx.doi.org/10.5320/wjr.v5.i2.166